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Cornelia de Lange syndrome (CdLS) is a rare genetically heterogeneous disorder with a high phenotypic variability including
mental retardation, developmental delay, and limb malformations. The genetic causes in about 30% of patients with CdLS are
still unknown. We report on the functional characterization of two intronic NIPBL mutations in two patients with CdLS that do
not affect a conserved splice-donor or acceptor site. Interestingly, mRNA analyses showed aberrantly spliced transcripts missing
exon 28 or 37, suggesting the loss of the branch site by the c.5329-15A>G transition and a disruption of the polypyrimidine by the
c.6344del(-13) (-8) deletion. While the loss of exon 28 retains the reading frame of the NIBPL transcript resulting in a shortened
protein, the loss of exon 37 shifts the reading framewith the consequence of a premature stop of translation. Subsequent quantitative
PCR analysis demonstrated a 30% decrease of the total NIPBL mRNA levels associated with the frameshift transcript. Consistent
with our results, this patient shows a more severe phenotype compared to the patient with the aberrant transcript that retains its
reading frame.Thus, intronic variants identified by sequencing analysis in CdLS diagnostics should carefully be examined before
excluding them as nonrelevant to disease.
1. Introduction
Cornelia de Lange syndrome (CdLS;OMIM 1227470, 300590,
610759, 614701, and 300882) is a rare congenital disorder
characterized by developmental delay, typical facial dys-
morphism, limb malformations, and gastrointestinal and
neurological problems [1]. CdLS is caused by mutations
affecting the cohesin complex, which participates in essential
cell processes such as chromosome segregation during cell
division, DNA repair and replication, and gene expression
[2]. Mutations have been identified in five different genes
(NIPBL, SMC1A, SMC3, HDAC8, and RAD21), encoding
structural or regulatory components of cohesin [2–9].
The NIPBL gene is located on chromosome 5p13.2. At
least 60% of the patients with the clinical diagnosis of CdLS
showNIPBLmutations [3–5].NIPBL spans more than 190 kb
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and contains 47 exons [10]. In addition to the previously
reported two isoforms, four new shorter transcripts that
exclude different combinations of exons 10, 12, 33 + 34, or 45
have been described recently [11].
Although mutations predicted to affect NIPBL splicing
represent about 15% of all known mutations in NIPBL,
their functional consequences on mRNA splicing are often
unknown [12]. Accurate mRNA splicing requires several
functional DNA elements, including a splice-donor and
acceptor site, a polypyrimidine tract, a branch point, and
further regulatory sequences that can either be located
within intronic or exonic regions of the gene body and act
as enhancers or silencers of the splicing process and are
mostly unknown [13]. Mutations in the highly conserved
AG/GT splice-acceptor and donor dinucleotides almost
always result in aberrant splicing [14], while the pathological
consequences of mutations in the other functional elements
are mostly unknown. To distinguish the latter mutations
from intronic polymorphisms, extensive in vitro analyses on
mRNA extracted from patient samples are needed [15].
In this paper we report for the first time on the identi-
fication and functional investigation of two intronic NIPBL
mutations that do not affect the conserved splice-donor
or acceptor sites. Sequencing analysis of the parents could
confirm the de novo status of either mutation in the patients.
We used in vitro as well as in vivo analyses to confirm the
functional consequences of bothmutations, andwehave tried
to correlate our findings with the phenotype of the patients.
2. Patients and Methods
2.1. Patients and Controls. This study includes two German
patients who meet clinical criteria for CdLS according to
Kline et al. [1]. The ethical standards of the Declaration of
Helsinki have been followed. Patients’ parents have written
informed consent to participate in the study. A pool of four
cDNAs from normal individuals was used as a control to
perform the experiments.
2.2. DNA Extraction and Sequence Analyses. Genomic DNA
was extracted from peripheral blood leukocytes using the
standard salting out procedure. The exons of the NIPBL
gene and their splice junctions were amplified by PCR.
The PCR products were purified with USB ExoSAP-IT PCR
Product Cleanup (Affymetrix) following the manufacturer’s
instructions and subsequently sequenced using an ADN 3130
Genetic Analyzer (Applied Biosystems).
NIPBL cDNA was numbered according to the NIPBL
isoform 1 (GenBank accession number NM 000642).
The mutation nomenclature was designated following the
instructions from the Human Genome Variation Society
(http://www.hgvs.org/).
2.3. RNA Extraction and Identification of Splice Transcripts
by RT-PCR. Total RNA from blood leukocytes of patients
and controls was extracted using the PAXgene Blood RNA
Kit (PreAnalytiX) according the manufacturer’s instructions.
Single-stranded cDNAs were synthesized from 500 ng of
RNA using the First-Strand Synthesis Kit (Fermentas) with
random hexamers.
Specific PCRs were performed for each patient. For
patient 1, exons 27–32 were amplified with primers sF27
(5耠-GGCCGTTTGCCCAGAGCTTTG-3耠) and sR32 (5耠-
AAACCAGTCATATCCAGTATC-3耠). For patient 2, exons
35–38 were amplified with primers sF35 (5耠-CATCATCAA-
ATATGGCATGAC-3耠) and sR38 (5耠-CTAGACCAATGA-
TAGCTTTTG-3耠). Each reaction contained 2 휇L of cDNA
in a 20 휇L mixture. Products obtained were analyzed by
electrophoresis on a 2% agarose gel. Bands were excised and
purifiedwithQIAEXGel ExtractionKit (QIAGEN), and their
identity was confirmed by sequencing.
2.4. Minigene Construction and Site-Directed Mutagenesis.
Minigene constructs were generated using vector pSPL3
(Exon Trapping System, Gibco, BRL, Carlsbad, CA, kindly
provided by Dr. B. Pe´rez). For patient 1, exon 28 and
its intronic flanking regions were amplified by PCR using
the primers NM28F (5耠-GGCTACAGGTTCTGCAAATG-
3耠) and NM28R (5耠-CCCATGTGGTTCCTATCATC). For
patient 2, exon 37 and its intronic flanking regions were
amplified using the primers NM37F (5耠-ATTACCTGAGGT-
CGGGAGTTC-3耠) and NM37R (5耠-GCTGTTGATGTC-
AACAGTGTGC-3耠). The same amplifications were carried
out on the genomic DNA from a healthy control.
The fragments were inserted into the pCR-2.1-TOPO
vector (InvitrogenCorporation) following themanufacturer’s
protocol. The inserts were excised with EcoRI (Fermentas)
and subsequently inserted into pSPL3. Ligation was per-
formed at 25∘C for 5min, using T4 DNA ligase (Invitrogen
Corporation).
Mutations introduced on pSPL3-WT were performed
with QuikChange Site-DirectedMutagenesis Kit (Stratagene,
La Jolla, CA, USA). On pSPL3-28-WT, we disrupted the
consensus branch point sequence maintaining the original
A at position c.5329-15 (YYRAY→RRYAR) to generate the
mutant BP. On pSPL3-37-WT, the pyrimidines deleted in
patient 2 were turned into purines to disrupt the polypyrim-
idine tract of exon 37, generating the mutant PUR.
Plasmids were isolated using the GeneJET Plasmid
Miniprep Kit (Fermentas) according to manufacturer’s
instructions and checked by sequencing.
2.5. Minigene Transfection and In Vitro Splicing Analysis.
HepG2 cells were transfected with 1500 ng of each minigene
using JetPEI reagent (Qbiogene Inc., Irvine, CA, USA) fol-
lowing the manufacturer’s instructions. Cells were harvested
at 48 hours after transfection and RNA was extracted using
RNeasy ProtectMini Kit (Qiagen). RT-PCR transcriptionwas
carried out with 1 휇g of RNA using the First-Strand Synthesis
Kit (Fermentas). PCRs were carried out on 5 휇L of cDNA
using the pSPL3-specific primers SD6 and SA2.The amplified
products were analyzed by electrophoresis and sequenced.
Each experiment was performed in triplicate.
2.6. Real-Time Quantitative PCR. Total NIPBL expression
was measured in both patients using primers NIPBL35-36F
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(5耠-GGCATGACTGTAGTGCAAC-3耠) and NIPBL 36R (5耠-
ATTGAAACAAGCCCACACAA-3耠). Real-time quantitative
PCR was performed in an ABI Prism 7000 sequence detector
system (Applied Biosystems). We used 1xSYBR Green PCR
Mastermix, 25 ng cDNA (total RNA equivalent), and 100 nM
primers for each reaction mix. The amplification conditions
were 95∘C for 10minutes, followed by 40 cycles of 95∘C for 15
seconds and 60∘C for 1minute.Melting curve analysis showed
a specific amplification. The same reactions were performed
on a pool of four control cDNAs as a reference. All the
amplifications were performed in triplicate.
We used standard curves to quantify the expression of
NIPBL, as well as GAPDH for normalization. To create the
standard curves, NIPBL and GAPDH cDNAs were inserted
into the pCR-2.1-TOPO vector according to the manufac-
turer’s protocol. Plasmids were quantified by spectrophoto-
metric analysis at 260 nm, and standard curves were based
on a 10-fold serial dilution of the different cloned genes.The
Ct (cycle threshold) values of the samples were interpolated
to the corresponding standard curve. The expression of
NIPBL was normalized to the expression of GAPDH in the
same sample. 푃 values were calculated using Student’s 푡-
test.
3. Results
3.1. Clinical Report. Patient 1 (P1) is an 8-year-old boy who
was born after an uneventful pregnancy at 41 weeks of
gestation. Birth weight was 3,260 g (−0.8 SD), length 50 cm
(−1.5 SD), and head circumference (HC) 34 cm (−1.6 SD).
The craniofacial features included arched eyebrows, long eye-
lashes, hypertelorism, depressed nasal bridge, long philtrum,
and thin upper lip. He had small hands with bilateral single
palmar crease and short 1st metacarpal (Figure 1(a)). Physical
exploration also demonstrated shawl scrotum, micropenis,
and hypospadias. Brain Evoked Auditory Response and
abdominal and cardiac ultrasounds were normal. At the age
of 7 years, his weight was 19 kg (median), his height was
112 cm (−2.2 SD), and his HC was 47 cm (−3.8 SD). Develop-
mental milestones were delayed. More clinical information is
provided in Table 1.
Patient 2 (P2) is a 7-year-old girl, who was born at
36 weeks of gestation. Birth weight was 2,130 g (−1.2 SD),
length 43 cm (−1.2 SD), and head circumference (HC) 30 cm
(−2.2 SD). During the exploration in the newborn period
she showed the following features: brachycephaly, arched
eyebrows with synophrys, long eyelashes, ptosis, depressed
nasal bridge with anteverted nostrils, long and smooth
philtrum, thin upper lip, low anterior and posterior hairline
with a webbed neck, generalized hirsutism, and cutis mar-
morata. She had small hands with brachymesophalangy V
and restriction of elbowmovements (Figure 1(b)). During the
firstmonths of life, she had a feeding and swallowing disorder,
which currently is under treatment, and she has underwent
surgery for treatment of gastroesophageal reflux. At the age of
one year, herweightwas 4630 g (−1.75 SD), height 63 cm (−4.8
SD), and HC 39 cm (−4.8 SD). More clinical information is
shown in Table 1.
3.2. DNA and RNA Analysis. Sequence analysis of the
genomic DNA yielded two novel intronic mutations in the
NIPBL gene. In patient 1 a transition (c.5329-15A>G in intron
27) and in patient 2 a deletion (c.6344del(-13) (-8) in intron
36) were identified (Figure 1(c)). Sequencing analysis of the
parents confirmed the de novo status for both mutations.
RNA analysis could prove aberrant splicing in both
patients. In patient 1, an aberrant transcript of 535 bp
beside the expected wild type PCR product of 634 bp was
observed. Sequencing analysis of the aberrantly spliced prod-
uct revealed a loss of a 99 bp fragment representing the
entire exon 28 region (Figure 1(c)). In patient 2 the expected
wild type product of 363 bp plus an additional product of
208 bp was detected. Subsequent sequencing analysis showed
a deletion of 155 bp representing exon 37 of the NIPBL gene
(Figure 1(c)).
3.3. Minigene Analysis of the Mutation c.6344del(-13) (-8).
Transfection using the exon 37 WT construct generated
two fragments, the main one of 423 bp containing exon 37
and another of 268 bp without this exon (Figure 2(a)). The
presence of the mutation c.6344del(-13) (-8) leads to a rise
of the transcript with exon 37 deletion while the normal
transcript disappeared (Figure 2(a)). The disruption of the
polypyrimidine tract of exon 37 (PUR) produced a similar
effect to mutation c.6344del(-13) (-8) (Figure 2(a)).
3.4. Quantification of NIPBL Expression in Patients. Total
NIPBL mRNA levels were assessed by quantitative real-time
PCR using oligonucleotides that recognize NIPBL sequences
not affected by aberrant or alterative splicing.The mean level
of total NIPBL expression measured in four control cDNAs
(CT) was assigned as 100% (SD = 5.1%), and the meanNIPBL
expression in each patient was referred as a percentage to the
control.
Whereas no distinct changes onNIPBLmRNA levelswere
observed in patient 1 (P1 = 96%, SD = 1.4%) a decrease of∼30% on total NIPBL mRNA levels was measured in patient
2 (P2 = 71%, SD = 1.4%, 푃 < 0.001) (Figure 2(b)).
4. Discussion
Here, we report and characterize for the first time two novel
de novo CdLS-causing mutations within intronic regions
of NIPBL that do not affect the conserved splice-donor or
acceptor site but result in aberrant mRNA splicing.
In patient 1 (P1), the A>G transition located at c.5329-
15 within intron 27 of NIPBL results in the skipping of
the adjacent exon (Figure 1(c)). This adenine (c.5329-15)
lies within a predicted branch point sequence YNYYRAY
(TGTCAAT) [16–18], which is in close proximity to the
splice-acceptor site and therefore might be involved in the
formation of the lariat structure during the splicing process.
This kind of mutation is often missed within molecular
diagnostics because there is no explicit consensus sequence
and branch points can be located at variable distances from
the acceptor site [19, 20]. However, the position of this
change, the surrounding nucleotides matching the consensus
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Table 1: Clinical features of two patients with CdLS.
Patient 1 Patient 2
Mutation c.5329-15A>G c.6344(−13) (−8)del
Predicted effect on protein p.(Ile1777 Arg1809del) p.(Gly2115Valfs∗11)
Clinical severity Mild Severe
Gender Male Female
Anthropometric data (newborn)
Gestational age 41weeks 36weeks
Birth weight 3260 g (−0.55 SD) 2130 g (−1.01 SD)
Birth length 50 cm (−0.46 SD) 43 cm (−1.73 SD)
Birth OFC 34 cm (−1.02 SD) 30 cm (−1.71 SD)
Intrauterine growth restriction − +
Anthropometric data (last evaluation)
Age at evaluation 7 years 1 year
Weight at evaluation 19 kg (−1.31 SD) 4630 g (−4.74 SD)
Length at evaluation 112 cm (−2.14 SD) 63 cm (−4.61 SD)
OFC at evaluation 47 cm (−4.07 SD) 39 cm (−6.05 SD)
Postnatal growth retardation + +
Limb defects Small hands, single palmarcrease, short 1st metacarpal
Small hands,
brachymesophalangy V,
restriction of the elbow
movements
Developmental delay +Speech delay
+
No speech
Learned walking at 3.5 years
Intellectual disability + +
Microcephaly + +
Behaviour impairment − +
GERD − +Floppy Nissen fundoplication
Feeding and swallowing disorders +
+
No chewing
Stomach tube until 5 years
Hirsutism − +
Cutis marmorata − +
GU anomalies Shawl scrotum, micropenishypospadias NA
Others
Recurrent infections
Nuchal cystic hygroma/nuchal
edema
+: present; −: not present; OFC: head circumference; CNS: central nervous system; NA: not available; GERD: gastroesophageal reflux disease; GU:
genitourinary; SD: standard deviation.
sequence, and A>G transition of the “lariat adenine” is the
most frequentmutation affecting proper lariat formation [21],
strongly suggesting the disruption of a branch point by this
mutation. In our minigene model, exon 28 WT showed a
big trend to skip, thus hindering subsequent analyses, maybe
due to the lack of some splicing regulatory sequences in the
model which are present in vivo. Nevertheless, a change in
the splicing pattern corresponding to an increase of exon
skippingwas observed in the presence of themutation c.5329-
15A>G as well as with the disruption of the branch point
sequence (data not shown).
The six-nucleotide deletion within intron 36 in patient
2 (P2), c.6344del(-13) (-8), causes skipping of exon 37 dur-
ing the splicing process (Figure 1(c)). The deletion disrupts
a polypyrimidine stretch located adjacent to the acceptor
sequence. Since these stretches are known to play a funda-
mental role in the splicing process, the deletion of six base
pairs, five of which are pyrimidines, within this functional
region, might explain the skipping of the exon [22]. Despite
the fact that a specific consensus sequence has not yet
been defined, it has been reported that a minimum tract is
required, and both its length and its composition contribute
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Figure 1: Overview of the phenotype and molecular findings of two patients with CdLS. (a) Phenotype of patient 1. (b) Phenotype of patient
2. (c) Localization of the mutations on NIPBL gene and their consequences upon transcript processing. Boxes mean exons and lines mean
introns. Dark boxes represent the nontranslated region.The localization of each mutation and chromatograms on genomic DNA are shown
above the gene. Agarose gel of the cDNA PCR products in each patient’ pictures and chromatograms are shown underneath the gene. Patient
1 yielded normal product of 634 bp and an aberrant fragment of 535 bp corresponding to exon 28 skipping. Patient 2 showed the normal
product of 363 bp and an additional band of 208 bp corresponding to exon 37 skipping (MW: molecular weight, WT: wild type, P1: patient 1,
and P2: patient 2).
to splicing efficiency [23, 24]. Although the most common
mutations are transversions of pyrimidines into purines [15],
this mutation would affect the length of the sequence. The
minigene carrying the deletion of c.6344del(-13) (-8) could
further confirm these findings. Furthermore, a transversion
of the five deleted pyrimidines into purines (PUR) also
results in a skipping of exon 37 which strongly supports the
functional relevance of this pyrimidine stretch for proper
NIPBL splicing (Figure 2(a)).
In general, frameshift mutations in NIPBL encoding a
truncated nonfunctional protein result in a reduced level of
functional NIPBL and are mostly associated with a severe
CdLS phenotype due to the genetic model of haploinsuffi-
ciency.Missensemutations aswell as small in-framedeletions
or insertions that preserve the reading frame of the transcript
are mostly detected in patients with more moderate pheno-
types [4, 25]. The phenotype of the patients with mutations
affectingNIPBL splicing seems to be in agreement with these
observations and are associatedwith the consequences for the
NIPBL protein encoded by the aberrantly spliced transcript
[11].
The mutation c.5329-15A>G results in an aberrantly
spliced NIPBL transcript that excludes a 99 bp fragment
representing exon 28 but it preserves the protein reading
frame and is supposed to result in a slightly shortened
NIPBL protein. This exon encodes parts of HEAT-repeat
domain of NIPBL. Although the precise function is still
unknown, protein-protein interactions were mapped within
the HEAT-repeat domain and there is a clear enrichment of
missense mutations affecting this part of the protein [26].
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Figure 2: Functional analyses of the intronic mutations c.5329-15A>G and c.6344del(-13) (-8). (a) Minigene constructs were generated by
site-directed mutagenesis. Deletion of c.6344del(-13) (-8) causes an exon skipping that was also found by a transversion of the five deleted
purines into pyrimidines (PUR). (b) Quantitative real-time PCR analysis of total NIPBLmRNA from leukocytes of patients with CdLS and
controls. NIPBL transcript levels were normalized by GAPDH expression.The values presented are the medians of triplicate determinations± SD.The mean ratio of total NIPBLmRNA in controls was assigned as 100% (CT: controls, P1: patient 1, P2: patient 2, and ∗ ∗ ∗: 푃 < 0.001
versus control).
However, at least a partial preservation of theNIPBL function
might be postulated, supported by the fact that numerous
missense mutations distributed over almost entire protein-
coding region of NIPBL result in similar CdLS phenotypes
[25]. Furthermore, quantitative analyses exclude a significant
reduction of the total NIPBL transcript levels in patient 1
compared to unaffected controls (Figure 2(b)). This is in
contrast to patient 2, who shows a significant reduction of
total NIPBL mRNA levels down to 71% of those observed
in controls (푃 < 0.001) (Figure 2(b)). We could show that
the deletion of c.6344del(-13) (-8) results in an aberrantly
spliced transcript that lacks exon 37which causes a shift in the
reading frame.The observed decrease of theNIPBL transcript
level down to 70%might be explained by nonsense-mediated
mRNA decay of the aberrant transcript which would be in
agreement with the proposed model of haploinsufficiency
[27–30].
The two patients described here meet the general CdLS.
It is of note that they present with different phenotypical
features. Patient 1 shows a rather mild phenotype without
intrauterine growth restriction and a slight postnatal retarda-
tion of height and weight. However he shows microcephaly.
He has feeding problems without GERD and minor limb
anomalies and his developmental delay is mild (Table 1).
By contrast, patient 2 shows a more severe phenotype with
evident craniofacial features even in the neonatal period,
limb abnormalities, profound growth, and psychomotor
retardation as well as severe microcephaly. In addition, she
suffered from severe GERD (Table 1). The association of
frameshift aberrant transcripts with severe CdLS pheno-
types has been previously suggested [11]. This work pro-
vides experimental support to this hypothesis, since clinical
findings are in agreement with our molecular analyses: a
general reduction of NIPBL mRNA levels and a transcript
that contains a frameshift or encodes a truncated protein
result in a more severe phenotype than alteration of protein
function/structure preserving the reading frame and totally
NIPBL levels [4, 25].
Furthermore, we could give functional evidence that
intronic variants which do not necessarily affect splice-donor
or acceptor site result in aberrantly splicedNIPBL transcripts
and are of pathological relevance for CdLS. Although recent
findings could reveal de novo mutations in the ANKRD11
gene in patients with the clinical diagnosis of CdLS, the
genetic causes in about 30% of patients with CdLS are still
unknown [31, 32]. Whether unknown mutations affecting
NIPBL splicing within the often large intronic regions that
are not totally covered by current sequencing analyses might
result in the CdLS phenotype can only be speculated. Thus,
intronic variants identified by sequencing analysis in CdLS
diagnostics should carefully be examined before excluding
them as nonrelevant to disease.
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5. Conclusions
We report on the functional characterization of two intronic
NIPBL mutations in two patients with CdLS that do not
affect a conserved splice-donor or acceptor site.While c.5329-
15A>G may disrupt a branch point in exon 27, c.6344del(-
13) (-8) would affect a polypyrimidine stretch in exon 37.
The deletion of c.6344del(-13) (-8) generates a frameshift
aberrant transcript resulting in NIPBL haploinsufficiency,
consistent with the severe phenotype of this patient. These
findings highlight the fact that intronic variants should
carefully be examined before excluding them as nonrelevant
to CdLS.
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